1. Home
  2. SONM vs ACXP Comparison

SONM vs ACXP Comparison

Compare SONM & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • ACXP
  • Stock Information
  • Founded
  • SONM 1999
  • ACXP 2017
  • Country
  • SONM United States
  • ACXP United States
  • Employees
  • SONM N/A
  • ACXP N/A
  • Industry
  • SONM Telecommunications Equipment
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • ACXP Health Care
  • Exchange
  • SONM Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • SONM 10.2M
  • ACXP 8.4M
  • IPO Year
  • SONM 2019
  • ACXP 2021
  • Fundamental
  • Price
  • SONM $0.95
  • ACXP $0.37
  • Analyst Decision
  • SONM
  • ACXP Strong Buy
  • Analyst Count
  • SONM 0
  • ACXP 2
  • Target Price
  • SONM N/A
  • ACXP $10.00
  • AVG Volume (30 Days)
  • SONM 150.3K
  • ACXP 142.6K
  • Earning Date
  • SONM 05-12-2025
  • ACXP 05-13-2025
  • Dividend Yield
  • SONM N/A
  • ACXP N/A
  • EPS Growth
  • SONM N/A
  • ACXP N/A
  • EPS
  • SONM N/A
  • ACXP N/A
  • Revenue
  • SONM $58,243,000.00
  • ACXP N/A
  • Revenue This Year
  • SONM $127.68
  • ACXP N/A
  • Revenue Next Year
  • SONM N/A
  • ACXP N/A
  • P/E Ratio
  • SONM N/A
  • ACXP N/A
  • Revenue Growth
  • SONM N/A
  • ACXP N/A
  • 52 Week Low
  • SONM $1.03
  • ACXP $0.30
  • 52 Week High
  • SONM $10.70
  • ACXP $3.33
  • Technical
  • Relative Strength Index (RSI)
  • SONM 29.91
  • ACXP 45.53
  • Support Level
  • SONM $1.31
  • ACXP $0.34
  • Resistance Level
  • SONM $1.50
  • ACXP $0.43
  • Average True Range (ATR)
  • SONM 0.15
  • ACXP 0.03
  • MACD
  • SONM -0.03
  • ACXP 0.00
  • Stochastic Oscillator
  • SONM 4.17
  • ACXP 32.45

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: